Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Trial to Reduce Delirium in Aged Post Acute Patients
Authors not listed
National Institute on Aging (NIA) · 2000
Abstract
The purpose of this study is to develop a comprehensive Delirium Abatement Program of care of delirious patients in the post acute care setting and to evaluate its impact on persistence and severity of delirium and on functional recovery.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Anonymous. (2000). A Trial to Reduce Delirium in Aged Post Acute Patients. <em>National Institute on Aging (NIA)</em>. https://clinicaltrials.gov/study/NCT00182936
Vancouver
Anonymous. A Trial to Reduce Delirium in Aged Post Acute Patients. National Institute on Aging (NIA). 2000.
BibTeX
@misc{anon2000ATrial,
title = {A Trial to Reduce Delirium in Aged Post Acute Patients},
author = {Anonymous},
journal = {National Institute on Aging (NIA)},
year = {2000},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Rheumatology Reports 2019
Preprint · OA
Adipokines: New Therapeutic Target for Osteoarthritis?
University of Utah 2026
Open access · US-GOV
Integration of Lesion-tailored, Fundus-controlled Perimetry Into Routine Clinical Care for Patients With Geographic Atrophy (GA) Receiving Pegcetacoplan Treatment in Accordance With the Approved Label.
PolyPhotonix Medical 2014
Open access · US-GOV
Noctura400 Treatment for Diabetic Retinopathy: Pilot Study to Demonstrate and Evaluate the Care Pathway for National Health Service (NHS) Adoption
Aging 2010
Open access · CC-BY
The sweet taste of death: glucose triggers apoptosis during yeast chronological aging
Rishi Singh 2012
Open access · US-GOV
A Single Arm, Investigator Initiated Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Injection in Subjects With Exudative Age-related Macular Degeneration Previously Treated With Ranibizumab or Bevacizumab (ASSESS Study)
Mayo Clinic Proceedings 2011
Open access · OA